Protein arginine methyltransferase 1(PRMT1) enhances CRC proliferation by asymmetrically dimethylating the non-POU domain-containing octamer-binding protein (NONO) at R251, facilitating epidermal growth factor receptor (EGFR) signaling activation and tumor progression (21–23). Here, PRMT1 is linked to neoplasm.